<div id="readability-page-1">03:59 PM EST, 12/09/2025 (MT Newswires) -- Health care stocks declined late Tuesday afternoon, with the NYSE Health Care Index down 0.6% and the State Street Health Care Select Sector SPDR ETF (XLV) decreasing 1%.The iShares Biotechnology ETF (IBB) fell 1.7%.In corporate news, Mirum Pharmaceuticals' ( MIRM ) acquisition of Bluejay Therapeutics expands its rare liver disease pipeline with brelovitug, a hepatitis delta virus therapy that has shown &#34;solid&#34; phase 2 results, Morgan Stanley said in a note Tuesday. Morgan Stanley kept its overweight rating and raised its price target to $95 from $81. Mirum shares were down 3.7%.Pfizer ( PFE ) said that it has signed an exclusive global collaboration and licensing deal with YaoPharma, a unit of Shanghai Fosun Pharmaceutical, to develop, make and commercialize YP05002 for chronic weight management. Pfizer ( PFE ) shares were down 1.7%.CVS Health ( CVS ) lifted its full-year outlook on Tuesday amid ongoing efforts to strengthen its core businesses, while the healthcare company said it expects earnings in 2026 to be higher than the previous year. Its shares rose 2.4%.Teleflex ( TFX ) said Tuesday it agreed to sell its Acute Care, Interventional Urology and OEM units for a combined $2.03 billion in cash. Its shares jumped 9.7%. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

MIRM

泰利福

輝瑞

西維斯

醫療保健股票下跌，紐約證券交易所醫療保健指數下跌 0.6%。Mirum Pharmaceuticals 收購了 Bluejay Therapeutics，擴展了其產品線。輝瑞與 YaoPharma 簽署了合作協議。CVS Health 上調了全年展望，預計 2026 年收益將更高。泰利福以 20.3 億美元出售了單位，推動股價上漲 9.7%

Sector Update: Health Care Stocks Softer Late Afternoon

- 健康護理股票下跌，NYSE 健康護理指數下降 0.6%。  
- Mirum Pharmaceuticals 收購 Bluejay Therapeutics，擴展肝病管線。  
- CVS Health 上調全年展望，Teleflex 同意出售多個單位。  

板塊更新：下午晚些時候醫療保健板塊股票表現疲軟